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Chloride channel CLCN5 mutations in Japanese children with familial proteinuria, hypercalciuria, nephrocalcinosis, nephroli-
idiopathic low molecular weight proteinuria. thiasis, rickets, and progressive renal failure [4]. This
Background. Familial idiopathic low molecular weight proteinuria
disease has phenotypic similarities to X-linked recessive(FILMWP) is a renal proximal tubulopathy characterized by mild
proteinuria consisting of low molecular weight proteinuria and rela- nephrolithiasis (XRN) [5] and X-linked recessive hypo-
tively conserved renal function in young patients, but without rickets. phosphatemic rickets (XLRH) [6]. However, there are
Mutations in the renal chloride channel CLCN5 gene have been re-
important differences, as rickets is absent in XRN, andported in three disorders of hypercalciuric nephrolithiasis and in
FILMWP. nephrocalcinosis and moderate renal failure are more
Methods. To assess the relationship between molecular defects and notable in XLRH. The isolation and characterization of
phenotypic variations, we analyzed the CLCN5 gene from three addi-
the complete open reading frame of the human CLCN5tional Japanese families with FILMWP using single-strand conforma-
tion polymorphism and sequencing. gene, mapped to Xp11.22, are predicted to encode a
Results. We identified three mutations: a single base insertion at protein of 746 amino acids, with significant homology to
codon 514; a single base deletion at codon 116; and a nonsense muta-
all known members of the CLC family of the voltage-tion, R704X. The R704X mutation is identical to that found in X-
linked recessive nephrolithiasis, but there was no renal failure in our gated chloride channel [7]. The coding region of the
patient. The first two mutations caused a shift in the reading frame, CLCN5 gene is organized into 12 exons, spanning 25
and all introduced a premature stop codon, resulting in synthesis of
to 30 kb of genomic DNA, and this CLCN5 gene istruncated CLC-5 proteins that lacked 220 (29%), 610 (82%), and 43
(6%) amino acids, respectively. These mutations were demonstrated responsible for these three disorders of hypercalciuric
to cosegregate with the disease in each of the three families. nephrolithiasis [8, 9].
Conclusions. We conclude that the CLCN5 gene is responsible for
Recent studies of Japanese children with FILMWPthe renal proximal tubulopathy in many Japanese families and suggest
that molecular defects, environmental factors, or other modifying genes with hypercalciuric nephrocalcinosis have demonstrated
may account for the different phenotypes. an association with mutations of the CLCN5 gene [10].
We reported CLCN5 mutations in two unrelated Japa-
nese patients with FILMWP [11]. The common genetic
Familial idiopathic low molecular weight proteinuria etiology of CLCN5 mutations and phenotypic similarities
(FILMWP) is a renal tubular disorder characterized by between three disorders of hypercalciuric nephrolithiasis
(a) mild proteinuria consisting of low molecular weight in whites and FILMWP in Japanese families indicates
proteinuria and low-grade albuminuria, usually without that they are possibly variants of one disorder. To pursue
hematuria; (b) aminoaciduria or glycosuria; (c) no growth further investigations to determine whether FILMWP is
retardation; (d) normal renal function in young patients; a variant of Dent’s disease and to define a correlation
and (e) a predominant appearance in males. These char- between the mutations and phenotypic variations, we ana-
acterizations have been noted in Japanese boy patients lyzed the CLCN5 gene from other unrelated Japanese
[1–3]. This disorder seems to have clinical heterogeneity. families with FILMWP and identified three mutations.
Dent’s disease is characterized by low molecular weight
METHODS
Key words: CLCN5 gene, proximal tubulopathy, Dent’s disease,
PatientsX-linked recessive nephrolithiasis, b2-microglobulin.
Patient L1 was a five-year-old boy with proteinuriaReceived for publication May 12, 1998
(1 g/day). The urinary protein to urinary creatinine ratioand in revised form July 27, 1998
Accepted for publication July 28, 1998 (UProt/Cr) was 3.6. Proteinuria was initially found at a uri-
nary screening of Japanese children at the age of three, 1999 by the International Society of Nephrology
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Table 1. Clinical and biochemical findings in Japanese patients Patient L5 was a six-year-old boy with proteinuria
with FILMWP
(UProt/Cr 6.5), which was initially found at the age of five
Family L1 L4 L5 months and which consisted of low molecular weight pro-
Age years 5 6 6 teinuria identified by b2m (49,400 mg/liter), lysozyme (27.5
Age at diagnosis years 3 6 0.4 mg/ml), and aminoaciduria. Microhematuria was present,
Sex M M M
but glycosuria was absent. Hypercalciuria was presentUrine
b2-microglobulin lg/liter 54,000 92,100 49,400 (UCa/Cr 0.88 mg/mg), and nephrocalcinosis was detected
Protein g/day 1 0.86 NE by computerized tomography scanning. Urinary concen-Protein/creatinine 3.6 2.1 6.5
trating ability was normal (urine specific gravity, 1.025).Occult blood 6 6 1
Ca/creatinine mg/mg 0.28 0.28 0.88 Urinary b2m was strikingly abnormal in a maternal uncle
%TRP % 82.4 NE 84.5 and two of the mother’s cousins and was slightly abnor-Osmolarity mOsm/liter 517 NE NE
mal in the mother (344 mg/liter) and the maternal grand-or specific gravity NE 1.025 1.025
Serum mother (3,192 mg/liter), whereas it was normal in the
Creatinine mg/dl 0.9 0.67 0.28 father. There was no rickets or incidence of renal failureCa mg/dl 10.2 10.0 9.2
in these three families.P mg/dl 4.1 3.3 4.4
Nephrocalcinosis or nephrolithiasis 2 2 1
Rickets 2 2 2 Materials and methods
Family history
Rickets 2 2 2 Genomic DNAs were extracted from peripheral leu-
Renal failure 2 2 2 kocytes from three unrelated Japanese individuals with
Abbreviations are: 1, present; 2, absent; NE, not examined. Nephrocalcinosis FILMWP, according to the standard method [12]. To
or nephrolithiasis was detected by computerized tomography and/or ultrasonog-
amplify exons 2 to 12 of the CLCN5 gene, 14 pairs ofraphy.
oligonucleotide primers were synthesized, based on flank-
ing intron and exon sequences of the gene [7]. The se-
quences of oligonucleotide primers were described else-which consisted of low molecular weight proteinuria
where [11]. Genomic DNA was amplified by polymeraseidentified by b2-microglobulin (b2m, 54,000 mg/liter),
chain reaction (PCR) [13, 14]. PCR conditions were de-lysozyme (104 mg/ml), a1-microglobulin (a1m, 104 mg/
scribed elsewhere [15]. For single-strand conformationliter), and aminoaciduria. Mild acidosis and a mild de-
polymorphism (SSCP) analysis [16], the amplified DNAcrease in tubular reabsorption of phosphate (%TRP,
was denatured at 948C for three minutes and electropho-82.4%) were present, but glycosuria and rickets were
resed under nondenaturing conditions on 7.5% poly-absent. Hypercalciuria was present (urinary Ca, 7.3 mg/
acrylamide gels with 6% glycerol and/or on 10% poly-kg/day); however, nephrocalcinosis and nephrolithiasis
were not detected by ultrasonography nor by computer- acrylamide gels with 10% glycerol at 48C at 100 V for 3
ized tomography scanning. An impaired urinary concen- to 10 hours. The DNA was detected after silver staining
trating ability (maximum urinary osmolarity, 517 mOsm/ [17]. The DNA sequence of abnormal SSCPs was deter-
liter) and a mild decrease in creatinine clearance (60 ml/ mined using a DNA sequencer, GENESCAN Model 373
min/1.73 m2) was present (Table 1). One maternal uncle A, and Taq Dye Deoxy Terminator Cycle Sequencing
had strikingly abnormal urinary b2m (42,000 mg/liter), Kit (Applied Biosystems, Foster City, CA).
but he did not have hypercalciuria or renal failure. Uri- For gene tracking in patient L1, normal (10YN) and
nary b2m was slightly abnormal in the patient’s mother mutant (10YM) primers were synthesized based on the
(2,100 mg/liter) and one maternal aunt (1,300 mg/liter), sequence of exon 10 [7]. The sequence of oligonucleotide
whereas it was normal in the father, the sister, and other primers for 10YN was 59-ATTTCTTTGCAGGTGGG
family members. GT-39, and the sequence for 10YM was 59-ATTTCTTT
Patient L4 was a six-year-old boy with proteinuria (0.86 GCAGGTGGGGGT-39.
g/day; UProt/Cr 2.1), consisting of low molecular weight DNAs were extracted from peripheral leukocytes of
proteinuria identified by b2m (92,100 mg/liter), lysozyme L1 family members and were amplified with primers(56.4 mg/ml), and a1m (120 mg/liter). Glycosuria, amino- 10YN/101B or 10YN/102B (wild-type allele) and withaciduria, acidosis, and rickets were absent. Urinary cal-
primers 10YM/101B or 10YM/102B (mutant allele).cium to urinary creatinine ratio (UCa/Cr) was 0.28 mg/mg,
Then they were electrophoresed on a 1.5% agarose gel.but nephrocalcinosis was not detected by ultrasonogra-
For gene tracking in L4 and L5 families, amplifiedphy. The urinary concentrating ability was normal (urine
DNAs of exons 4 and 11 from family members werespecific gravity, 1.025). The maternal uncle had elevated
digested with restriction enzyme AspI (restriction site,urinary b2m (40,900 mg/liter), and the sister and the ma-
GACN/NNGTC) and BslI (CCNNNNN/NNGG), re-ternal grandmother had mild elevated urinary b2m (1,110
spectively. The products were electrophoresed on 4%and 927 mg/liter, respectively), whereas it was normal in
the father and mother (84 and 178 mg/liter, respectively). NuSieve GTG agarose gels.
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Table 2. CLCN5 mutations in Japanese FILMWP
Amino acid Restriction enzyme
Family Codon Base change (aa) change change/PCR Decuded protein
Frame shift mutation
L1 V514 ins G 13 missense PCR Missense peptide from amino acids 514–526 and loss of 220
aa and stop amino acids from D12 to C terminus
L4 C116 del T 21 missense Aspl Missense peptide from amino acids 116–136 and loss of 610
aa and stop amino acids from a partial of D2 to C terminus
Nonsense mutation
L5 R704 CGA → TGA Arg → Stop Bsl l Loss of 43 amino acids at C terminus
RESULTS site in exon 4, the restriction enzyme was used for gene
tracking in the L4 family. There was no AspI site in theWe screened exons 2 to 12 of the CLCN5 gene for
amplified product (247 bp) of exon 4 from a normalmutations using PCR-SSCP analysis. In patients L1 and
control. When amplified DNAs from the patient (III1)L4, no abnormal bands were detected in any exons of
and a maternal uncle (II1) were digested with AspI, athe gene on 7.5% polyacrylamide gels with 6% glycerol
247 bp fragment was absent, and two new fragments (172in the previous study [11]. However, on 10% polyacryl-
and 74 bp) appeared (Fig. 3). The patient’s mother (II3),amide gels with 10% glycerol, mobilities of the amplified
the sister (III2), and the maternal grandmother (I2) wereDNAs of patients L1 and L4 were clearly different from
heterozygous with both mutant and wild-type alleles.those of control samples with regard to exons 10 and
The father (II2) and the grandfather (I1) carried the4, respectively. In patient L5, an abnormal band was
wild-type allele.detected in exon 11 on both gel conditions (data not
As the mutation in patient L5 lost a BslI site in exonshown). No other abnormal SSCP patterns were ob-
11, the enzyme was used for gene tracking in the L5served with the 10 remaining exons in three patients,
family. When the amplified DNA from a normal controlrespectively.
was digested with BslI, two fragments (210 and 61 bp)In patient L1, sequencing of amplified products re-
appeared (Fig. 4). There was no BslI site in the amplifiedvealed a single base “G” insertion at codon 514 valine
product (271 bp) from patient L5 (II1). The patient’s[7], and this mutation caused a shift in the reading frame
mother (I2) was heterozygous with both mutant andof 13 amino acids and introduced a premature termina-
wild-type alleles. The father (I1) carried only the wild-tion signal TGA at codon 527. In patient L4, sequencing
type allele.revealed a single base “T” deletion at codon 116 cysteine,
and this mutation caused a shift in the reading frame of
21 amino acids and introduced a premature termination
DISCUSSIONsignal TAG at codon 137. In patient L5, sequencing
We examined the CLCN5 gene in three other unre-revealed a C to T transition, converting codon 704 argi-
lated Japanese patients with FILMWP and identifiednine to a stop codon (CGA → TGA) (Table 2 and Fig. 1).
three mutations: a single base insertion, a single baseThese mutations in patient L1, L4, and L5 resulted in
deletion, and a nonsense mutation. The first two weresyntheses of the truncated CLC-5 proteins that lacked
novel mutations. Each mutation was confirmed and dem-220 (29%), 610 (82%), and 43 (6%) amino acids at its
onstrated to cosegregate with the disease by using geno-carboxyl terminus, respectively.
mic DNA together with sequence-specific PCR primersFor gene tracking in the L1 family, we synthesized
or by using restriction enzymes. In addition, the absenceprimers 10YN to detect a wild-type allele and 10YM for
of these CLCN5 abnormalities in 30 alleles from 20 (10a mutant one. A fragment of wild-type allele was positive
males and 10 females) unrelated, normal individuals es-in the patient’s father (I8), the sister (II3), a maternal
tablished that they were not common polymorphismsuncle (I4), two aunts (I1 and I5), and two cousins (II1
(data not shown).and II2). A fragment of mutant allele was positive in the
Thirty-three disease-associated CLCN5 genetic abnor-patient (II4) and a maternal uncle (I6). The mother (I9)
malities have been reported in the renal proximal tubulopa-and a maternal aunt (I3) were heterozygous with both
thies: five FILMWP in the Japanese families we identified,mutant and wild-type alleles (Fig. 2). To exclude PCR
10 FILMWP in other Japanese (referred to as Dent’sJAPAN)errors, the results were confirmed by three other inde-
families, 13 Dent’s disease in British and other families,pendent amplifications and by using primers 10YN/102B
two XRN in North American families, two XLRH inand 10YM/102B instead of 10YN/101B and 10YM/101B,
Italian and French families, and one X-linked renal fail-respectively (data not shown).
As the mutation in patient L4 generated a new AspI ure without rickets in a United States family, respectively
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Fig. 2. Pedigree of patient L1 and gene tracking by PCR with normal and mutant primers. (A) Pedigree of patient L1. Symbols are: (s) unaffected
female, (h) unaffected male, (s• ) obligate female carrier, and (j) affected male. The patient (II4) is indicated by an arrowhead. (B) Amplification
of DNAs with normal primers 10YN/101B (lane n) and mutant primers 10YM/101B (lane m) and electrophoresis on a 1.5% agarose gel.
Abbreviations: C is a normal male control, and M is a 1 kb ladder marker. The lanes correspond to the family member immediately above them
in A. The patient (II4) and a maternal uncle (I6) have only a mutant allele (a 236 bp fragment). The patient’s father (I8), the sister (II3), a
maternal uncle (I4), two aunts (I1 and I5), and two cousins (II1 and II2) have only the wild-type allele (a 235 bp fragment). The mother (I9) and
a maternal aunt (I3) have both mutant and wild-type alleles, indicating that they are heterozygous.
[8–11, 20, 22]. The CLCN5 mutations were found to tient L2 [11]. Both mutations create a truncated CLC-5
protein that lacks 220 amino acids, although the numberbe spread all over the gene, although a clustering of
mutations was observed in some regions. Of the total 33 of missense codons in patient L1 is more than that in
patient L2 (13 versus 7 codons). Both patients have simi-CLCN5 mutations, eight (24%) have been identified in
or near the transmembrane domain 11 (D11), which is lar clinical findings, except for greater severity of tubular
dysfunction in the older patients in the L2 family. Inencoded by exons 9 and 10. The W279X and S244L
mutations have been observed three times (9%), and the patient L4, the mutation predicts a change in the D1–D2
loop and D2 and the absence of a partial region of D2R648X, R704X, and S520 mutations have been observed
twice in unrelated families, suggesting potential “hot to the C-terminal region. The R704X mutation in patient
L5 predicts the absence of D13 to C-terminal region.spots” for mutations. Seven mutations (21%) have been
observed in exon 8, which is correlated with the number Domain D13 is conserved in all eukaryotic CLC proteins,
suggesting that D13 and the C-terminal region play anof codons encoded by exon 8 (181 amino acids, 23%).
Of the 33 mutations, two were microdeletions that en- important role. The mutations in this study generate
truncated CLCN5 mRNAs and proteins. Because thecompass the entire CLCN5 gene, and three were splice
site mutations. Twenty-eight amino acids that have been truncated protein is generally unstable, it is possible that
truncation of this protein abolishes the function of theobserved to harbor mutations are highly conserved in
CLC members CLC-3, CLC-4, and CLC-5 [7], indicating channel. Accordingly, we speculate that the mutations
are causative for the disease. Of the five mutations wethe functional importance of these regions.
Mutations in the CLCN5 gene generate diseases such identified, the mutation in patient L4 generates the most
truncated CLC-5 protein, although clinical symptoms ofas Dent’s disease, XLRH, XRN, and FILMWP; however,
the relationship between genotype and phenotype re- patient L4 are not as severe as those of other patients.
There is a report that a portion of the C terminus exertedmains unknown [8]. In patient L1, the mutation predicts
a change of domain D11 and the absence of D12 to the an inhibitory effect on channel activity in other channels
[23]. Functional studies of these mutations in a heterolo-C-terminal region of CLC-5 protein [8]. We found a
single base insertion in codon 520 serine in another pa- gous expression system will prove the severity of muta-
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Fig. 3. Pedigree of patient L4 and gene tracking by restriction enzyme Asp I digestion of amplified DNA of exon 4. (A) Pedigree of patient L4.
Symbols are: (h) unaffected male, (s• ) obligate female carrier, and (j) affected male. The patient (III1) is indicated by an arrowhead. (B)
Digestion of amplified DNA with AspI and electrophoresis on a 4% NuSieve gel. C is a normal male control; M is a 1 kb ladder marker. The
lanes correspond to the family member immediately above them in A. (C) The restriction map of the AspI site, which is indicated by a vertical
line. The patient (III1) and a maternal uncle (II1) are missing a normal fragment of 247 bp and have variant fragments of 172 bp and 74 bp. The
patient’s mother (II3), the sister (III2), and the maternal grandmother (I2) are heterozygous with normal and variant fragments. The father (II2)
and the grandfather (I1) have a normal fragment.
tions and the function of residual or lacking regions of the quantity of calcium intake or the time of exposure
to the sun. Further investigations of CLCN5 expressionthe protein.
Clinical features of FILMWP are similar to those of along the human nephron using anti-CLC5 antibodies
and of mechanisms whereby CLCN5 mutations lead toDent’s disease and two related disorders. However, there
are notable differences of clinical phenotypes: in Japanese low molecular weight proteinuria, hypercalciuria, and
renal failure will lead to increased understanding of renalfamilies, rickets or renal failure do not occur. The R704X
mutation in patient L5 is identical to a mutation found tubular function and pathology.
It is evident that urinary b2m is less markedly abnormalin a North American family with XRN and renal failure
[5, 8]. Clinical features are similar in both patients, except in heterozygous females (less than 10,000 mg/liter) [24,
25]. However, the patient’s mother (II3) in family L4that our patient shows no renal failure. The patient with
XRN is older than our patient, and the difference in has a normal urinary b2m level, and we have reported
heterozygous females with normal urinary b2m [11]. Thisphenotypic expression may be explained by the differ-
ence in age. However, there is no renal failure in any might be accounted for by the Lyon hypothesis of ran-
dom inactivation of one X chromosome in nephrons inaffected family members of patient L5, according to his
mother. This may be accounted for by differences of not females. Analysis of the CLCN5 gene will aid in diagnos-
ing heterozygotes for FILMWP.only CLCN5 mutations but also other modifying genes,
age, and environmental factors such as diet, especially Lloyd et al reported that SSCP analysis was found to
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Fig. 4. Pedigree of patient L5 and gene tracking
by restriction enzyme Bsl I digestion of amplified
DNA of exon 11. (A) Pedigree of patient L5.
Symbols are: (h) unaffected male, (s• ) obligate
female carrier, and (j) affected male. Patient
(II1) is indicated by an arrowhead. (B) Digestion
of amplified DNA with Bsl I and electrophoresis
on a 4% NuSieve gel. C is a normal male control;
M is a 1 kb ladder marker. The lanes correspond
to the family member immediately above them
in A. (C) The restriction map of the Bsl I site,
which is indicated by a vertical line. When the
amplified DNA from a normal control (C) is di-
gested with Bsl I, two fragments (210 and 61 bp)
appear. There is no Bsl I site in the amplified
product (271 bp) from patient L5 (II1). The father
(I1) has normal fragments. The mother (I2) is
heterozygous with normal and variant fragments.
be a sensitive and specific mutational screening method APPENDIX
that detected more than 75% of CLCN5 mutations [10]. Abbreviations used in this article are: a1m, a1 microglobulin; b2m,
b2 microglobulin; FILMWP, familial idiopathic low molecular weightOur findings indicate that analysis by SSCP on two gel
proteinuria; PCR, polymerase chain reaction; SSCP, single-strand con-conditions may help detect mutations. formation polymorphism; UCa/Cr, urinary calcium-to-urinary creatinine
We conclude that the CLCN5 gene is responsible for ratio; UProt/Cr, urinary protein-to-urinary creatinine ratio; XLRH,
X-linked recessive hypophosphatemic rickets; XRN, X-linked recessivethe renal proximal tubulopathy in many Japanese fami-
nephrolithiasis.
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